234 results on '"Zéphir, Hélène"'
Search Results
2. Frequency and clinical relevance of MOG-antibodies in CSF in pediatric patients with MOG antibody-associated diseases
3. Choroid plexus enlargement correlates with periventricular pathology but not with disease activity in radiologically isolated syndrome.
4. Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society
5. Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study
6. Real-life study to assess effectiveness and safety of eculizumab in patients with neuromyelitis optica spectrum disorders in France: protocol for ECUP4, an observational study
7. COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022
8. Comparison of 2 Methods for Estimating Multiple Sclerosis–Related Mortality
9. Indications de l’autogreffe dans la sclérose en plaques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) en lien avec la Société francophone de la sclérose en plaques
10. Complications neurologiques post-allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
11. Optical coherence tomography for detection of asymptomatic optic nerve lesions in clinically isolated syndrome
12. Asymptomatic optic nerve lesions: An underestimated cause of silent retinal atrophy in MS
13. The biological sample collection of the OFSEP French MS registry: An essential tool dedicated to researchers
14. Proinflammatory B-cell profile in the early phases of MS predicts an active disease
15. Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system
16. A Scleroderma Patient Presenting with Facial Pain
17. Signes et symptômes de la sclérose en plaques
18. Diagnostics différentiels de la sclérose en plaques
19. Thérapeutiques et prise en charge de la sclérose en plaques
20. Diagnostic positif de la sclérose en plaques
21. Late-onset of Alpers-Huttenlocher syndrome: an unusual cause of refractory epilepsy and liver failure
22. Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system.
23. Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability
24. A Spontaneous Model of Experimental Autoimmune Encephalomyelitis Provides Evidence of MOG-Specific B Cell Recruitment and Clonal Expansion
25. Comparison of 3D double inversion recovery and 2D STIR FLAIR MR sequences for the imaging of optic neuritis: pilot study
26. sj-docx-1-msj-10.1177_13524585221139156 – Supplemental material for Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system
27. Étude du parcours de soin des patients atteints d’un syndrome neurologique associé aux anticorps antineuronaux au CHU de Lille grâce aux nouveaux outils informatiques de Data Science
28. Autoimmune cerebellar ataxia with glutamic acid decarboxylase 65 antibodies associated with central vestibular symptoms
29. Longitudinal Retinal Changes in MOGAD.
30. Anti-JCV antibody prevalence in a French cohort of MS patients under natalizumab therapy
31. Changes in self-reactive IgG antibody repertoire after treatment of experimental autoimmune encephalomyelitis with anti-allergic drugs
32. Diversified serum IgG response involving non-myelin CNS proteins during experimental autoimmune encephalomyelitis
33. Long-term Follow-up of Acute Partial Transverse Myelitis
34. Switching for convenience from first-line injectable treatments to oral treatments in multiple sclerosis: Data from a retrospective cohort study
35. Long-term effect of natalizumab in patients with RRMS: TYSTEN cohort
36. Double‐blind , randomized controlled trial of therapeutic plasma exchanges vs sham exchanges in moderate‐to‐severe relapses of multiple sclerosis
37. Severe and rapidly evolving peripheral neuropathy revealing sporadic Creutzfeldt-Jakob disease
38. Optical Coherence Tomography in Neuromyelitis Optica
39. Neuromyelitis Optica and Non–Organ-Specific Autoimmunity
40. Cognitive Functions in Neuromyelitis Optica
41. The long‐term outcome of MOGAD: An observational national cohort study of 61 patients.
42. Treating asymptomatic bacteriuria before immunosuppressive therapy during multiple sclerosis: Should we do it?
43. Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study
44. Optical coherence tomography: a window to the optic nerve in clinically isolated syndrome
45. Optic nerve double inversion recovery hypersignal in patients with clinically isolated syndrome is associated with asymptomatic gadolinium-enhanced lesion
46. Long-term effect of natalizumab in patients with RRMS: TYSTEN cohort.
47. Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies.
48. Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France.
49. Optic nerve double inversion recovery hypersignal in patients with clinically isolated syndrome is associated with asymptomatic gadolinium-enhanced lesion.
50. Altered B lymphocyte homeostasis and functions in systemic sclerosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.